FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3047361396> ?p ?o ?g. }

• W3047361396 endingPage "3593" @default.
• W3047361396 startingPage "3586" @default.
• W3047361396 abstract "Abstract High-dose methotrexate (HD-MTX) is increasingly used as prophylaxis for patients with diffuse large B-cell lymphoma (DLBCL) at high risk of central nervous system (CNS) relapse. However, there is limited evidence to guide whether to intercalate HD-MTX (i-HD-MTX) between R-CHOP-21 (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone given at 21-day intervals) or to give it at the end of treatment (EOT) with R-CHOP-21. We conducted a retrospective, multicenter analysis of 334 patients with DLBCL who received CNS prophylaxis with i-HD-MTX (n = 204) or EOT HD-MTX (n = 130). Primary end points were R-CHOP delay rates and HD-MTX toxicity. Secondary end points were CNS relapse rate, progression-free survival, and overall survival. The EOT group had more patients with a high CNS international prognostic index (58% vs 39%; P &lt; .001) and more concurrent intrathecal prophylaxis (56% vs 34%; P &lt; .001). Of the 409 cycles of i-HD-MTX given, 82 (20%) were associated with a delay of next R-CHOP (median, 7 days). Delays were significantly increased when i-HD-MTX was given after day 9 post–R-CHOP (26% vs 16%; P = .01). On multivariable analysis, i-HD-MTX was independently associated with increased R-CHOP delays. Increased mucositis, febrile neutropenia, and longer median inpatient stay were recorded with i-HD-MTX delivery. Three-year cumulative CNS relapse incidence was 5.9%, with no differences between groups. There was no difference in survival between groups. We report increased toxicity and R-CHOP delay with i-HD-MTX compared with EOT delivery but no difference in CNS relapse or survival. Decisions on HD-MTX timing should be individualized and, where i-HD-MTX is favored, we recommend scheduling before day 10 of R-CHOP cycles." @default.
• W3047361396 created "2020-08-10" @default.
• W3047361396 creator A5002478152 @default.
• W3047361396 creator A5007016445 @default.
• W3047361396 creator A5009176644 @default.
• W3047361396 creator A5015988282 @default.
• W3047361396 creator A5016350720 @default.
• W3047361396 creator A5020447255 @default.
• W3047361396 creator A5025210308 @default.
• W3047361396 creator A5028077862 @default.
• W3047361396 creator A5028707549 @default.
• W3047361396 creator A5034090582 @default.
• W3047361396 creator A5037565105 @default.
• W3047361396 creator A5052261054 @default.
• W3047361396 creator A5053298824 @default.
• W3047361396 creator A5056513534 @default.
• W3047361396 creator A5062633357 @default.
• W3047361396 creator A5064305763 @default.
• W3047361396 creator A5067708761 @default.
• W3047361396 creator A5072527039 @default.
• W3047361396 creator A5082526059 @default.
• W3047361396 creator A5083109893 @default.
• W3047361396 date "2020-08-06" @default.
• W3047361396 modified "2023-09-30" @default.
• W3047361396 title "Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery" @default.
• W3047361396 cites W173609426 @default.
• W3047361396 cites W1995939575 @default.
• W3047361396 cites W2035098923 @default.
• W3047361396 cites W2072228041 @default.
• W3047361396 cites W2085687297 @default.
• W3047361396 cites W2089242301 @default.
• W3047361396 cites W2096047333 @default.
• W3047361396 cites W2142991507 @default.
• W3047361396 cites W2154868392 @default.
• W3047361396 cites W2155495849 @default.
• W3047361396 cites W2171356556 @default.
• W3047361396 cites W2462981464 @default.
• W3047361396 cites W2496211488 @default.
• W3047361396 cites W2590821302 @default.
• W3047361396 cites W2734666624 @default.
• W3047361396 cites W2742627598 @default.
• W3047361396 cites W2794015106 @default.
• W3047361396 cites W2894051390 @default.
• W3047361396 cites W2905175512 @default.
• W3047361396 cites W2914256533 @default.
• W3047361396 cites W2919015634 @default.
• W3047361396 cites W2923453543 @default.
• W3047361396 cites W2927138762 @default.
• W3047361396 cites W2951720456 @default.
• W3047361396 cites W2953052900 @default.
• W3047361396 cites W2971529736 @default.
• W3047361396 cites W3023631491 @default.
• W3047361396 cites W4293241248 @default.
• W3047361396 doi "https://doi.org/10.1182/bloodadvances.2020002421" @default.
• W3047361396 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7422120" @default.
• W3047361396 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32761231" @default.
• W3047361396 hasPublicationYear "2020" @default.
• W3047361396 type Work @default.
• W3047361396 sameAs 3047361396 @default.
• W3047361396 citedByCount "34" @default.
• W3047361396 countsByYear W30473613962021 @default.
• W3047361396 countsByYear W30473613962022 @default.
• W3047361396 countsByYear W30473613962023 @default.
• W3047361396 crossrefType "journal-article" @default.
• W3047361396 hasAuthorship W3047361396A5002478152 @default.
• W3047361396 hasAuthorship W3047361396A5007016445 @default.
• W3047361396 hasAuthorship W3047361396A5009176644 @default.
• W3047361396 hasAuthorship W3047361396A5015988282 @default.
• W3047361396 hasAuthorship W3047361396A5016350720 @default.
• W3047361396 hasAuthorship W3047361396A5020447255 @default.
• W3047361396 hasAuthorship W3047361396A5025210308 @default.
• W3047361396 hasAuthorship W3047361396A5028077862 @default.
• W3047361396 hasAuthorship W3047361396A5028707549 @default.
• W3047361396 hasAuthorship W3047361396A5034090582 @default.
• W3047361396 hasAuthorship W3047361396A5037565105 @default.
• W3047361396 hasAuthorship W3047361396A5052261054 @default.
• W3047361396 hasAuthorship W3047361396A5053298824 @default.
• W3047361396 hasAuthorship W3047361396A5056513534 @default.
• W3047361396 hasAuthorship W3047361396A5062633357 @default.
• W3047361396 hasAuthorship W3047361396A5064305763 @default.
• W3047361396 hasAuthorship W3047361396A5067708761 @default.
• W3047361396 hasAuthorship W3047361396A5072527039 @default.
• W3047361396 hasAuthorship W3047361396A5082526059 @default.
• W3047361396 hasAuthorship W3047361396A5083109893 @default.
• W3047361396 hasBestOaLocation W30473613961 @default.
• W3047361396 hasConcept C126322002 @default.
• W3047361396 hasConcept C143998085 @default.
• W3047361396 hasConcept C2776694085 @default.
• W3047361396 hasConcept C2776715498 @default.
• W3047361396 hasConcept C2776755627 @default.
• W3047361396 hasConcept C2777063308 @default.
• W3047361396 hasConcept C2778476033 @default.
• W3047361396 hasConcept C2778496288 @default.
• W3047361396 hasConcept C2778559949 @default.
• W3047361396 hasConcept C2778850193 @default.
• W3047361396 hasConcept C2779338263 @default.
• W3047361396 hasConcept C2779429289 @default.
• W3047361396 hasConcept C2779725641 @default.

• next